a team of researchers at new york university’s langone medical center found that, out of 84 patients treated with the combination of hydroxychloroquine and azithromycin, 11 percent had qt prolongation beyond 500 milliseconds — the proven danger zone for sudden cardiac death.
a team of researchers at new york university’s langone medical center found that, out of 84 patients treated with the combination of hydroxychloroquine and azithromycin, 11 percent had qt prolongation beyond 500 milliseconds — the proven danger zone for sudden cardiac death.